BIMI Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
23 Avril 2024 - 10:05PM
BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”),
previously known as BIMI International Medical Inc., a healthcare
products and services provider, today announced that on April 19,
2024, it received a delinquency compliance alert notice from the
Listing Qualifications Department of The Nasdaq Stock Market LLC
(“Nasdaq”) advising the Company that due to the Company’s failure
to timely file its Annual Report on Form 10-K for the fiscal year
ended December 31, 2023, with the Securities and Exchange
Commission (the “SEC”), the Company is not in compliance with
Nasdaq’s continued listing requirements under Nasdaq Listing Rule
5250(c)(1) (the “Rule”), which requires the timely filing of all
required periodic reports with the SEC.
Nasdaq provided the Company 60 days to submit a plan to regain
compliance with the Rule (the “Plan”). The Company intends to
submit its plan of compliance to Nasdaq by June 18, 2024. If Nasdaq
accepts the Plan, the Company may be granted an extension of 180
calendar days from the due date of the Form 10-K, or until October
14, 2024, to regain compliance with the Rule. In the event the Plan
is not accepted by Nasdaq, the Company may appeal that decision to
a Hearings Panel.
About BIMI Holdings Inc.BIMI Holdings Inc. is a
healthcare products and services provider, offering a broad range
of healthcare products and related services in the U.S. and Asia.
For more information, please visit usbimi.com.
Forward-Looking StatementsThis announcement
contains forward-looking statements as defined under Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, formulated in accordance with the 'safe
harbor' provisions of the Private Securities Litigation Reform Act
of 1995. These statements, reflecting the Company's projections
about its future financial and operational performance, employ
terms like 'believes,' 'estimates,' 'anticipates,' 'expects,'
'plans,' 'projects,' 'intends,' 'potential,' 'target,' 'aim,'
'predict,' 'outlook,' 'seek,' 'goal,' 'objective,' 'assume,'
'contemplate,' 'continue,' 'positioned,' 'forecast,' 'likely,'
'may,' 'could,' 'might,' 'will,' 'should,' 'approximately,' and
similar expressions to convey the uncertainty of future events or
outcomes. These forward-looking statements are based on the
Company's current expectations, assumptions, and projections,
involving judgments about future economic conditions, competitive
landscapes, market dynamics, and business decisions, many of which
are inherently challenging to predict accurately and are largely
beyond the Company's control. Additionally, these statements are
subject to a multitude of known and unknown risks, uncertainties,
and other variables that could significantly diverge the Company's
actual results from those depicted in any forward-looking
statement. These factors include, but are not limited to, varying
economic conditions, competitive pressures, and regulatory changes.
Because of these and other risks, uncertainties and assumptions,
undue reliance should not be placed on these forward-looking
statements. In addition, these statements speak only as of the date
of this press release and, except as may be required by law, the
Company undertakes no obligation to revise or update publicly any
forward-looking statements for any reason.
Investor Relations ContactInvestor Relations
Department of BIMI Holdings Inc.Email: vinson@usbimi.com Tel: +1
949 981 6274
BIMI International Medical (NASDAQ:BIMI)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
BIMI International Medical (NASDAQ:BIMI)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024